100-Year Human Aging Study

ConditionsAging Aging Well All-Cause Mortality Mortality Metabolic Syndrome Cardiovascular Diseases Cognitive Dysfunction Musculoskeletal Diseases Neoplasms Frailty Activities of Daily Living Health-Related Quality of Life Disability Physical Neuro-Degenerative Disease Dementia

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorLongevity Metrics, Inc.

About this trial

The 100-Year Human Aging Study is a prospective, pragmatic, observational trial enrolling participants across fixed and mobile clinical sites to undergo comprehensive multi-system health screening and longitudinal follow-up until death. Participants are followed to determine whether measurements taken at enrollment and repeated across the lifespan - individually and in combination - predict all-cause mortality, cause-specific mortality, incident serious disease, and functional disability. The study is designed to generate the surrogate endpoint validation data that longevity medicine currently lacks.

Eligibility criteria

Qualifiers

Age 18 years or older

Willing and able to provide written informed consent, or enrollment with consent of a legally authorized representative

Willing to participate in longitudinal follow-up

Disqualifiers

Age under 18 years

Trial design

Treatments tested in this trial

Comprehensive Multi-System Clinical Screening

Treatment groups

No treatment groups listed

Sponsors and collaborators

Longevity Metrics, Inc.

Lead sponsor

Source ClinicalTrials.gov